The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
DSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Apr 2010 09:30

RNS Number : 0209K
Dillistone Group PLC
12 April 2010
 



12 April 2010

 

 

DILLISTONE GROUP PLC

 

BOARD APPOINTMENT

 

Dillistone Group Plc ("Dillistone" or the "Company"), the AIM quoted supplier of recruitment software, is pleased to announce that Julie Patricia Pomeroy will join the board of Dillistone ("Board") as Finance Director with effect from 19 April 2010.

 

Julie, 54, is an experienced finance director of quoted and private companies and the Board is confident that she will be an asset to the Company. Julie graduated with an honours degree in physics from Birmingham University. She is a Chartered Accountant and Chartered Director as well as holding tax and treasury qualifications. Julie was group finance director of Carter & Carter Group plc until October 2005 having joined in 2002 to help grow and float the business. She had previously been chief financial officer of Weston Medical Group plc and prior to this, Julie worked at East Midlands Electricity plc as director of corporate finance. In August 2006 Julie was appointed to the role of finance director of AIM quoted Biofutures International plc and will continue in this role. Julie is also a non-executive director of Nottinghamshire Healthcare NHS Trust.

 

Mike Love, Chairman of Dillistone, commented:

"We are delighted to welcome Julie to the Board. We believe that Julie's experience as a director of both private and public companies will be an invaluable asset to the Company in her role as Finance Director. We look forward to Julie making a significant contribution to the continued development of Dillistone."

 

Julie is currently a director of Biofutures International Plc.

 

In the past 5 years Julie has been a director of the following companies:

 

Carter and Carter Group plc

Carter and Carter Limited

Carter and Carter Apprentice Learning Limited (previously EMTEC Holdings Limited)

EMTEC Colleges Limited

EMTEC (Specialised Services) Limited

EMTEC (Leicestershire) Limited

EMTEC (Derbyshire) Limited

Motor Systems Limited

 

Julie Pomeroy resigned as a director of WGP 1 Limited (formerly known as Weston Medical Group plc), WGP 100 Limited (formerly known as Weston Medical Limited) and WMG (1) Limited (formerly known as Intraject Limited) on 30 November 2002. These companies went into members voluntary liquidation on 28 February 2003 which has now been completed with a small return to shareholders.

 

 

Julie does not hold any shares in Dillistone.

 

In accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies, the Company confirms that there are no further matters to be disclosed in respect of Julie Pomeroy's appointment.

 

Contacts:

 

Mike Love Dillistone Group Plc 0207 749 6100

Chairman

 

Jason Starr Dillistone Group Plc 0207 749 6100

Managing Director

 

Emily Staples (Nomad) Religare Capital Markets 0207 444 0800

 

Daniel Briggs (Broker) Religare Capital Markets 0207 444 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUQPCUPUUMP
Date   Source Headline
20th Apr 20204:40 pmRNSSecond Price Monitoring Extn
20th Apr 20204:35 pmRNSPrice Monitoring Extension
20th Apr 20202:05 pmRNSSecond Price Monitoring Extn
20th Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSCOVID-19 and Results Date Update
8th Apr 20207:00 amRNSBlock listing Interim Review
6th Feb 20207:00 amRNSTrading Update & Notice of Results
10th Jan 20207:00 amRNSGatedTalent registers 100,000th new member
18th Dec 20197:00 amRNSCorporate Update & Board Changes
14th Oct 20199:37 amRNSBlock listing Interim Review
10th Oct 20197:00 amRNSGatedTalent Global Directory of Exec Search Firms
27th Sep 20197:00 amRNSHalf-year Report
4th Jul 20197:00 amRNSIssue of Options
26th Jun 20193:29 pmRNSResult of AGM
26th Jun 20197:00 amRNSAGM Statement
6th Jun 20197:00 amRNSLoan Agreements Update
30th Apr 20197:00 amRNSFinal Results
9th Apr 20197:00 amRNSBlock listing Interim Review
27th Feb 20193:30 pmRNSTrading Statement, Update & Notice of Results
22nd Jan 20197:00 amRNSMajor Contract Award & GatedTalent Update
5th Nov 20187:00 amRNSGatedTalent Update
10th Oct 20187:00 amRNSGatedTalent registers 20,000th executive member
9th Oct 20187:00 amRNSBlock listing Interim Review
28th Sep 201812:00 pmRNSReplacement Half-year Report
28th Sep 20187:00 amRNSHalf-year Report
4th Sep 20187:00 amRNSTrading Update & Notice of Results
26th Jun 201812:27 pmRNSResult of AGM
26th Jun 20187:00 amRNSAGM Trading Update
27th Apr 20187:00 amRNSFinal Results
20th Apr 201810:47 amRNSBlock listing Interim Review
27th Feb 20187:00 amRNSGatedTalent signs 100th client contract
8th Feb 20187:00 amRNSTrading Update & Notice of Results
7th Dec 20177:00 amRNSGatedTalent demand surpasses expectations
10th Nov 20177:00 amRNSIssue of Options
2nd Nov 20177:00 amRNSLaunch of GatedTalent & draw down of Loan Notes
10th Oct 201710:11 amRNSBlock listing Interim Review
28th Sep 20177:02 amRNSNew Product Launch - GatedTalent
28th Sep 20177:01 amRNSIssue of Loan Notes
28th Sep 20177:00 amRNSHalf-year Report
7th Jun 201711:58 amRNSResult of AGM
5th Jun 20177:00 amRNSTrading & New Product Update
26th Apr 20177:00 amRNSFinal Results
19th Apr 20177:00 amRNSBlock listing Interim Review
8th Feb 20177:00 amRNSTrading Update & Notice of Results
17th Oct 20167:00 amRNSGrant of Options to Directors/PDMR & Shareholdings
10th Oct 201611:10 amRNSBlock listing Interim Review
21st Sep 20167:00 amRNSHalf-year Report
1st Aug 20167:00 amRNSNotice of Results & Investor Access Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.